These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice. Yassin A, Saad F, Hoesl CE, Traish AM, Hammadeh M, Shabsigh R. Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236 [Abstract] [Full Text] [Related]
13. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia. Ng CF, Wong A, Cheng CW, Chan ES, Wong HM, Hou SM. J Urol; 2008 Sep; 180(3):1042-6. PubMed ID: 18639296 [Abstract] [Full Text] [Related]
15. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M, ALF-ONE Study Group. BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317 [Abstract] [Full Text] [Related]
17. The role of combination medical therapy in benign prostatic hyperplasia. Greco KA, McVary KT. Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123 [Abstract] [Full Text] [Related]
18. Doxazosin in elderly patients with hypertension. Weinberger MH, Fawzy A. Int J Clin Pract; 2000 Apr; 54(3):181-9. PubMed ID: 10829361 [Abstract] [Full Text] [Related]
20. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia. Rosen R, Seftel A, Roehrborn CG. Int J Impot Res; 2007 Apr; 19(5):480-5. PubMed ID: 17717526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]